This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Johns Hopkins University, Capricor, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019-2025
Title: The Innovations of Stephen John Gould
Introduction
Stephen John Gould is an accomplished inventor based in Baltimore, MD (US). He holds 2 patents that reflect his significant contributions to the field of biotechnology. His work primarily focuses on the development of innovative vaccine technologies and extracellular vesicle applications.
Latest Patents
Gould's latest patents include groundbreaking inventions such as the "Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms." This invention relates to modular systems for vaccination against infectious agents, utilizing exosome-loaded, antigen-encoding mRNAs to enhance immune responses. Another notable patent is "Extracellular vesicles for agent delivery," which provides methods and compositions for using extracellular vesicles as vectors for nucleic acid treatment in vivo, particularly for diseases like cholangiocarcinoma.
Career Highlights
Throughout his career, Gould has worked with prestigious organizations, including Johns Hopkins University and Capricor, Inc. His research and innovations have positioned him as a key figure in the biotechnology sector, contributing to advancements in vaccine development and therapeutic applications.
Collaborations
Gould has collaborated with notable colleagues such as Tariq Hussain Warsi and Florin M Selaru, further enhancing the impact of his work through shared expertise and innovative ideas.
Conclusion
Stephen John Gould's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in vaccine technology and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile